Maggie Fick on Muck Rack

Maggie Fick

Verified
  • European Pharmaceuticals Industry Correspondent, Reuters
London
As seen in: Reuters, MSN, MSN Australia, MSN Canada, MSN Ireland, MSN Money Canada, MSN Singapore, MSN UK, UOL, Yahoo Entertainment, Business Insider and
European Pharmaceuticals Industry correspondent @Reuters. Previously reporting from Africa and the Middle East for @Reuters @FT @AP since 2010.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Maggie

Contact Maggie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

German lawmakers approve healthcare shake-up aimed at taming costs

|
By Andreas Rinke Verified, Maria Martinez, Maria Martínez Verified, María Martínez, María Del Pilar Martínez Verified, Maggie Fick Verified
| MSN Verified
Andreas Rinke, Maria Martinez and Maggie Fick By Andreas Rinke, Maria Martinez and Maggie Fick BERLIN, July 10 (Reuters) - Germany's upper house gave final parliamentary approval on Friday to a bill aimed at reining in health insurance costs, despite fierce criticism from drugmakers who say the measures will deter pharmaceutical industry investment in the country.
Open in Who Shared View Duplicates (21) Issue with article?

German lawmakers approve healthcare shake-up aimed at taming costs

|
By Andreas Rinke Verified, Maria Martinez, Maria Martínez Verified, María Martínez, María Del Pilar Martínez Verified, Maggie Fick Verified
| The State Verified
BERLIN - Germany's upper house gave final parliamentary approval on Friday to a bill aimed at reining in health insurance costs, despite fierce criticism from drugmakers who say the measures will deter pharmaceutical industry investment in the country. Drugmakers including Eli Lilly, AstraZeneca, Pfizer and Merck KGaA have said the proposals send the wrong signal as Europe seeks to compete with the U.S. and China for life sciences investment in research and manufacturing.
Open in Who Shared View Duplicates (2) Issue with article?

German lawmakers approve healthcare shake-up aimed at taming costs

|
By Andreas Rinke Verified, Maria Martinez, Maria Martínez Verified, María Martínez, María Del Pilar Martínez Verified, Maggie Fick Verified
| The Sun News Verified
BERLIN - Germany's upper house gave final parliamentary approval on Friday to a bill aimed at reining in health insurance costs, despite fierce criticism from drugmakers who say the measures will deter pharmaceutical industry investment in the country. Drugmakers including Eli Lilly, AstraZeneca, Pfizer and Merck KGaA have said the proposals send the wrong signal as Europe seeks to compete with the U.S. and China for life sciences investment in research and manufacturing.
Open in Who Shared View Duplicates (7) Issue with article?
See all 15,783 licensed articles (17,031 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified